Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data.

T W Rice1, T E M R Lerut2, M B Orringer3

  • 1Cleveland Clinic, Cleveland, Ohio, USA. ricet@ccf.org.

Summary

Pathologic stage groupings after neoadjuvant therapy (ypTNM) for esophageal cancer have different prognostic implications than those after esophagectomy alone (pTNM). Separate ypTNM staging is recommended for improved prognostication in esophageal cancer patients.